Marvel Biosciences Corp. (MRVL:TSXV) closed at $0.130 on November 13, 2026, up 4.00% on the day. The stock trades 48.0% below its 52-week high of $0.250 and 36.8% above its 52-week low of $0.095. Over the past year, it lost 25.7%. Marvel Biosciences Corp. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, MRVL closed higher on 76 days (30%). Its best day was June 3, 2026 (+56.25%) and its worst was April 9, 2026 (-20.59%). The stock moved 10% or more in a single session 20 times. It opened at least 5% above the previous day's high 6 times.
Marvel Biosciences Corp is a life sciences company focused on the discovery and the development of a synthetic derivative compound of a known proven drug. It has developed several new patented and patentable chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression and anxiety, Alzheimer's, ADHD and addiction), cancer, and application to the non-neurological disease of non-alcoholic steatohepatitis liver fibrosis.
Find more stocks like MRVL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.